Market Size of Europe Pharmaceutical Cold Chain Logistics Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 19.59 Billion |
| Market Size (2029) | USD 31.32 Billion |
| CAGR (2024 - 2029) | 10.00 % |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Europe Pharmaceutical Cold Chain Logistics Market Analysis
The Europe Pharmaceutical Cold Chain Logistics Market size is estimated at USD 19.59 billion in 2024, and is expected to reach USD 31.32 billion by 2029, growing at a CAGR of 10% during the forecast period (2024-2029).
Europe is home to some of the largest pharmaceutical and life sciences companies, including Roche Holding (Switzerland), Sanofi (France), GlaxoSmithKline (United Kingdom), AstraZeneca (United Kingdom), Novo Nordisk (Denmark), Merck Group (Germany), Allergan (Ireland), UCB (Belgium), Ipsen (France), and Lundbeck (Denmark), among others. Several pharmaceutical and life sciences companies are investing in Europe owing to the potential and opportunities it provides. Companies have been getting into M&As, opening manufacturing plants, investing in warehouses, technology advancements, etc., to expand their product offerings and improve their market share.
Owing to the large pharmaceutical market, Europe is one of the largest importers and exporters of pharmaceuticals. The United States and Switzerland were the EU's main trading partners for medicinal products in 2020. Among the EU member states, Germany was the largest exporter (EUR 49 billion) of medicinal products in 2020. The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents around 1,900 pharmaceutical companies operating in Europe.
National pharmaceutical industry associations in the following 33 European countries are members of EFPIA: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, the Netherlands, Norway, Poland, Portugal, Romania, the Russian Federation, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, and the United Kingdom. In addition, 40 leading pharmaceutical companies are EFPIA members. COVID-19 further accelerated the demand for drugs and vaccines across Europe, which, in turn, drove the growth of the pharmaceutical logistics market in Europe.
Europe Pharmaceutical Cold Chain Logistics Industry Segmentation
Pharmaceutical logistics is related to the handling, transport, and chain management of multiple and varied products, the vast majority of which require specific conditions in their logistic treatment.
The European pharmaceutical cold chain logistics market is segmented by product (generic drugs, branded drugs), by application (bio-pharma, chemical pharma), by mode of transport (air shipping, rail shipping, road shipping, and sea shipping), by country (Germany, United Kingdom, Netherlands, France, Italy, Spain, Poland, Belgium, Sweden, and Rest of Europe).
The report offers the market sizes and forecasts for the European pharmaceutical cold chain logistics market in value (USD) for all the above segments.
| By Product | |
| Generic Drugs | |
| Branded Drugs |
| By Application | |
| Bio-Pharma | |
| Chemical Pharma |
| By Mode of Transport | |
| Air Shipping | |
| Rail Shipping | |
| Road Shipping | |
| Sea Shipping |
| By Country | |
| Germany | |
| United Kingdom | |
| Netherlands | |
| France | |
| Italy | |
| Spain | |
| Poland | |
| Belgium | |
| Sweden | |
| Rest of Europe |
Europe Pharmaceutical Cold Chain Logistics Market Size Summary
The European pharmaceutical cold chain logistics market is experiencing significant growth, driven by the region's status as a hub for major pharmaceutical and life sciences companies. With key players like Roche Holding, Sanofi, and AstraZeneca, Europe is a focal point for investments in manufacturing, technology, and logistics to enhance market share and product offerings. The region's robust pharmaceutical market also positions it as a leading importer and exporter of medicinal products, with Germany being a notable exporter within the EU. The European Federation of Pharmaceutical Industries and Associations (EFPIA) plays a crucial role in representing the interests of numerous pharmaceutical companies across Europe, further bolstering the industry's growth. The demand for pharmaceutical logistics has been accelerated by the COVID-19 pandemic, which underscored the necessity for efficient distribution of drugs and vaccines.
The market's expansion is further fueled by the increasing need for temperature-controlled transportation and warehousing, as approximately 80% of pharmaceutical products in the EU now require such conditions. This demand is driven by the development of complex biopharmaceuticals and the need to maintain product quality during transportation. The European Union's guidelines on Good Distribution Practices have extended temperature requirements to include transportation, enhancing the focus on cold chain logistics. The market is characterized by a mix of regional and global players, with companies like DHL, FedEx, and Kuehne + Nagel leading the charge. Investments in new facilities and transportation infrastructure are on the rise, as seen with Lineage Logistics and Maersk, aiming to meet the growing demand for reliable cold chain solutions.
Europe Pharmaceutical Cold Chain Logistics Market Size - Table of Contents
-
1. MARKET INSIGHTS
-
1.1 Current Market Scenario
-
1.2 Industry Supply Chain/Value Chain Analysis
-
1.3 Technological Trends
-
1.4 Government Regulations and Initiatives
-
1.5 Investment Scenario
-
1.6 Spotlight on Europe 3PL Market
-
1.7 Impact of Covid-19 on the Market
-
-
2. MARKET SEGMENTATION
-
2.1 By Product
-
2.1.1 Generic Drugs
-
2.1.2 Branded Drugs
-
-
2.2 By Application
-
2.2.1 Bio-Pharma
-
2.2.2 Chemical Pharma
-
-
2.3 By Mode of Transport
-
2.3.1 Air Shipping
-
2.3.2 Rail Shipping
-
2.3.3 Road Shipping
-
2.3.4 Sea Shipping
-
-
2.4 By Country
-
2.4.1 Germany
-
2.4.2 United Kingdom
-
2.4.3 Netherlands
-
2.4.4 France
-
2.4.5 Italy
-
2.4.6 Spain
-
2.4.7 Poland
-
2.4.8 Belgium
-
2.4.9 Sweden
-
2.4.10 Rest of Europe
-
-
Europe Pharmaceutical Cold Chain Logistics Market Size FAQs
How big is the Europe Pharmaceutical Cold Chain Logistics Market?
The Europe Pharmaceutical Cold Chain Logistics Market size is expected to reach USD 19.59 billion in 2024 and grow at a CAGR of 10% to reach USD 31.32 billion by 2029.
What is the current Europe Pharmaceutical Cold Chain Logistics Market size?
In 2024, the Europe Pharmaceutical Cold Chain Logistics Market size is expected to reach USD 19.59 billion.
